XRTX:NASDAQ, XORTX Therapeutics Inc.

XRTX stock overview

XORTX Therapeutics Inc. (XRTX:NASDAQ) closed at $0.930 on October 21, 2026, down 6.05% on the day. The stock trades 76.1% below its 52-week high of $3.89 and 3.3% above its 52-week low of $0.900. Over the past year, it lost 70.1%. XORTX Therapeutics Inc. is part of the Health Care sector.

Key figures

Price: $0.930
Day change: -6.05%
Volume: 72,286
Average volume: 720,243
Market cap: 1M+
52-week range: $0.900 – $3.89
50-day average: $1.90
200-day average: $2.20

Price action over the past year

In 252 trading sessions since October 20, 2025, XRTX closed higher on 104 days (41%). Its best day was April 8, 2026 (+30.70%) and its worst was October 20, 2025 (-31.82%). The stock moved 10% or more in a single session 26 times. It opened at least 5% above the previous day's high 4 times.

Recent signals

Oct 21, 2026: Hit a new 52-Week Low of $0.956 (New Highs/Lows scanner)
Oct 9, 2026: Dropped 23.8% in a single session (Dips & Crashes scanner)
Oct 8, 2026: News catalyst: Biotech (News Catalysts scanner)
Sep 18, 2026: Spiked to $2.65 on 7M+ shares (Spikes scanner)

XRTX news

Oct 8, 2026: XORTX Outlines Anticipated Health Canada Clinical Trial Application for XRx-026 for Gout
Sep 18, 2026: XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity
Sep 18, 2026: XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO, Targeting USD$700M+ U.S. Gout Market Opportunity
Sep 10, 2026: XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO
Sep 10, 2026: XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™
Sep 8, 2026: XORTX Re-Engages Investor Relations Program
Aug 28, 2026: XORTX Announces Termination and Postponement of Investor Relations Program
Jul 31, 2026: XORTX Announces Director Resignation

About XORTX Therapeutics Inc.

XORTX Therapeutics Inc is focused on developing drug therapies for orphan disease like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which include cardiovascular disease and diabetes.

Similar stocks

Find more stocks like XRTX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.